amitriptyline has been researched along with Bulbar Palsy in 3 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kvale, JN | 1 |
| Colenda, CC | 1 |
| Newman, GC | 1 |
1 trial available for amitriptyline and Bulbar Palsy
| Article | Year |
|---|---|
Treatment of progressive supranuclear palsy with tricyclic antidepressants.
Topics: Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Bulbar Palsy, Progressive; Clinical Trials as | 1985 |
2 other studies available for amitriptyline and Bulbar Palsy
| Article | Year |
|---|---|
Amitriptyline in the management of progressive supranuclear palsy.
Topics: Amitriptyline; Bulbar Palsy, Progressive; Humans; Male; Middle Aged | 1982 |
Antiarrhythmic properties of amitriptyline.
Topics: Aged; Amitriptyline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bulbar Palsy, Progressive; Cerebr | 1990 |